The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II – Therapy

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

2002 • 18,132 citations

Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?

2016 • 11,500 citations

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients

2000 • 8,612 citations

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

2003 • 3,816 citations

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial

2005 • 2,895 citations

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

2003 • 2,653 citations

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

2004 • 2,571 citations

Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both

2003 • 2,402 citations

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)

2003 • 2,138 citations

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial

1998 • 1,429 citations

Effects of Comprehensive Lifestyle Modification on Blood Pressure Control

2003 • 1,314 citations

Angiotensin-Converting–Enzyme Inhibition in Stable Coronary Artery Disease

2004 • 1,106 citations

Health Outcomes Associated With Various Antihypertensive Therapies Used as First-Line Agents

2003 • 1,103 citations

CHARM IN-VESTIGATORS AND COMMITTEES. EFFECTS OF CANDESARTAN IN PATIENTS WITH CHRONIC HEART FAILURE AND REDUCED LEFT-VENTRICULAR SYSTOLIC FUNCTION TAKING ANGIOTENSIN-CONVERTING-ENZYME INHIBITORS: THE CHARM-ADDED TRIAL

2003 • 1,046 citations

Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis

2005 • 992 citations

Effects of Blood Pressure Lowering With Perindopril and Indapamide Therapy on Dementia and Cognitive Decline in Patients With Cerebrovascular Disease

2003 • 963 citations

Morbidity and Mortality After Stroke, Eprosartan Compared With Nitrendipine for Secondary Prevention

2005 • 767 citations

Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial

2005 • 626 citations

Prevention of Coronary and Stroke Events with Atorvastatin in Hypertensive Patients who have Average or Lower-than-Average Cholesterol Concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial???Lipid Lowering Arm (ASCOT-LLA)

2004 • 539 citations

Cardiovascular prevention and blood pressure reduction

2003 • 495 citations

Awareness, Treatment, and Control of Hypertension in Canada

1997 • 358 citations

Clinical Outcomes in Antihypertensive Treatment of Type 2 Diabetes, Impaired Fasting Glucose Concentration, and Normoglycemia

2005 • 288 citations

Benefits of 2 Years of Intense Exercise on Bone Density, Physical Fitness, and Blood Lipids in Early Postmenopausal Osteopenic Women

2004 • 249 citations

Improvement in medical risk factors and quality of life in women and men with coronary artery disease in the Multicenter Lifestyle Demonstration Project

2003 • 187 citations

Lifestyle Modification as a Means to Prevent and Treat High Blood Pressure

2003 • 175 citations

Do fixed-dose combination pills or unit-of-use packaging improve adherence? A systematic review.

2004 • 159 citations

Adherence to Antihypertensive Therapy With Fixed‐Dose Amlodipine Besylate/Benazepril HCl Versus Comparable Component‐Based Therapy

2003 • 154 citations

The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II – Therapy

2006 • 139 citations

Impact of Pharmacy Counseling on Compliance and Effectiveness of Combination Lipid‐Lowering Therapy in Patients Undergoing Coronary Artery Revascularization: A Randomized, Controlled Trial

2000 • 115 citations

The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.

2004 • 93 citations

The 2004 Canadian recommendations for the management of hypertension: Part III--Lifestyle modifications to prevent and control hypertension.

2004 • 89 citations

The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy.

2005 • 70 citations

The 2001 Canadian recommendations for the management of hypertension: Part two--Therapy.

2002 • 61 citations

A novel process for updating recommendations for managing hypertension: rationale and methods.

2000 • 58 citations

Meta-analyses of mortality and morbidity effects of an angiotensin receptor blocker in patients with chronic heart failure already receiving an ACE inhibitor (alone or with a β-blocker)

2004 • 52 citations

Active-control equivalence trials and antihypertensive agents

2001 • 49 citations

The 2000 Canadian recommendations for the management of hypertension: Part one--therapy.

2001 • 37 citations

Deleted Work

1955 • 0 citations